Correction To: Risk of Relapse After Anti-Pd1 Discontinuation in Patients with Hodgkin Lymphoma (European Journal of Nuclear Medicine and Molecular Imaging, (2020), 10.1007/S00259-020-05015-2)
AuthID
P-00T-PQK
P-00T-PQK